Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 7
2004 13
2005 7
2006 7
2007 6
2008 3
2009 4
2010 10
2011 18
2012 13
2013 17
2014 16
2015 14
2016 15
2017 15
2018 12
2019 18
2020 20
2021 23
2022 14
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Results by year

Filters applied: . Clear all
Page 1
A high-stringency blueprint of the human proteome.
Adhikari S, Nice EC, Deutsch EW, Lane L, Omenn GS, Pennington SR, Paik YK, Overall CM, Corrales FJ, Cristea IM, Van Eyk JE, Uhlén M, Lindskog C, Chan DW, Bairoch A, Waddington JC, Justice JL, LaBaer J, Rodriguez H, He F, Kostrzewa M, Ping P, Gundry RL, Stewart P, Srivastava S, Srivastava S, Nogueira FCS, Domont GB, Vandenbrouck Y, Lam MPY, Wennersten S, Vizcaino JA, Wilkins M, Schwenk JM, Lundberg E, Bandeira N, Marko-Varga G, Weintraub ST, Pineau C, Kusebauch U, Moritz RL, Ahn SB, Palmblad M, Snyder MP, Aebersold R, Baker MS. Adhikari S, et al. Among authors: marko varga g. Nat Commun. 2020 Oct 16;11(1):5301. doi: 10.1038/s41467-020-19045-9. Nat Commun. 2020. PMID: 33067450 Free PMC article. Review.
Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.
Megyesfalvi Z, Barany N, Lantos A, Valko Z, Pipek O, Lang C, Schwendenwein A, Oberndorfer F, Paku S, Ferencz B, Dezso K, Fillinger J, Lohinai Z, Moldvay J, Galffy G, Szeitz B, Rezeli M, Rivard C, Hirsch FR, Brcic L, Popper H, Kern I, Kovacevic M, Skarda J, Mittak M, Marko-Varga G, Bogos K, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Schelch K, Laszlo V, Dome B. Megyesfalvi Z, et al. Among authors: marko varga g. J Pathol. 2022 Aug;257(5):674-686. doi: 10.1002/path.5922. Epub 2022 May 25. J Pathol. 2022. PMID: 35489038 Free PMC article.
Age-associated differences in the human lung extracellular matrix.
Koloko Ngassie ML, De Vries M, Borghuis T, Timens W, Sin DD, Nickle D, Joubert P, Horvatovich P, Marko-Varga G, Teske JJ, Vonk JM, Gosens R, Prakash YS, Burgess JK, Brandsma CA. Koloko Ngassie ML, et al. Among authors: marko varga g. Am J Physiol Lung Cell Mol Physiol. 2023 Jun 1;324(6):L799-L814. doi: 10.1152/ajplung.00334.2022. Epub 2023 Apr 11. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 37039368
Unfolding the secrets of small cell lung cancer progression: Novel approaches and insights through rapid autopsies.
Megyesfalvi Z, Heeke S, Drapkin BJ, Solta A, Kovacs I, Boettiger K, Horvath L, Ernhofer B, Fillinger J, Renyi-Vamos F, Aigner C, Schelch K, Lang C, Marko-Varga G, Gay CM, Byers LA, Morris BB, Heymach JV, Van Loo P, Hirsch FR, Dome B. Megyesfalvi Z, et al. Among authors: marko varga g. Cancer Cell. 2023 Sep 11;41(9):1535-1540. doi: 10.1016/j.ccell.2023.08.007. Cancer Cell. 2023. PMID: 37699331
The Immune System and the Proteome.
Marko-Varga G, LaBaer J. Marko-Varga G, et al. J Proteome Res. 2017 Jan 6;16(1):1. doi: 10.1021/acs.jproteome.6b00607. J Proteome Res. 2017. PMID: 28056507 No abstract available.
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.
Valko Z, Megyesfalvi Z, Schwendenwein A, Lang C, Paku S, Barany N, Ferencz B, Horvath-Rozsas A, Kovacs I, Schlegl E, Pozonec V, Boettiger K, Rezeli M, Marko-Varga G, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Grusch M, Laszlo V, Dome B, Schelch K. Valko Z, et al. Among authors: marko varga g. Br J Cancer. 2023 May;128(10):1850-1861. doi: 10.1038/s41416-023-02219-9. Epub 2023 Mar 14. Br J Cancer. 2023. PMID: 36918717 Free PMC article.
Current status of clinical proteogenomics in lung cancer.
Nishimura T, Nakamura H, Végvári Á, Marko-Varga G, Furuya N, Saji H. Nishimura T, et al. Among authors: marko varga g. Expert Rev Proteomics. 2019 Sep;16(9):761-772. doi: 10.1080/14789450.2019.1654861. Epub 2019 Aug 21. Expert Rev Proteomics. 2019. PMID: 31402712 Review.
Cancer heterogeneity determined by functional proteomics.
Szász AM, Győrffy B, Marko-Varga G. Szász AM, et al. Among authors: marko varga g. Semin Cell Dev Biol. 2017 Apr;64:132-142. doi: 10.1016/j.semcdb.2016.08.026. Epub 2016 Aug 26. Semin Cell Dev Biol. 2017. PMID: 27569188 Review.
In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer.
Szeitz B, Megyesfalvi Z, Woldmar N, Valkó Z, Schwendenwein A, Bárány N, Paku S, László V, Kiss H, Bugyik E, Lang C, Szász AM, Pizzatti L, Bogos K, Hoda MA, Hoetzenecker K, Marko-Varga G, Horvatovich P, Döme B, Schelch K, Rezeli M. Szeitz B, et al. Among authors: marko varga g. Clin Transl Med. 2022 Sep;12(9):e1060. doi: 10.1002/ctm2.1060. Clin Transl Med. 2022. PMID: 36149789 Free PMC article.
243 results